Stock screenerAll disclosures →
EDGAR →
TYRA
Conviction 49HealthcareScan · Thu, Jun 25, 2026Three white soldiers
TYRA$30.93+1.84%
ResistanceSupportVol 14Vol MA14 1.16M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price30.93
Change+1.84%
Gap-0.33%
Rel volume1.68×
Avg volume1.09M
Avg $ vol30.97M
SMA 2028.70
SMA 5032.41
SMA 20026.54
Price vs 50-4.58%
Price vs 200+16.56%
MA stackmixed
50/200 cross—
Supertrenddown · 31.31
RSI (14)54
MACD hist0.63
MACD crossbull · 6d
Stoch %K / %D92 / 86
ADX (14)23
+DI / −DI15 / 16
RSI divergence—
MACD divergence—
ATR %+6.17%
ADR %6.74%
52w high39.61
52w low9.10
From 52w high-21.91%
Above 52w low+239.89%
New 52w highNo
SqueezeOff
Bollinger width30.31%
%B0.76
Donchian pos67.82%
Donchian high33.91
Donchian low24.66
AVWAP (52w high)33.00
vs AVWAP high-6.28%
AVWAP (52w low)28.69
vs AVWAP low+7.81%
OBV trendFlat
Chaikin MF (20)-0.14
Today vs 20d1.68×
Avg vol (14d)1.16M
Avg vol (20d)1.09M
Avg $ vol (20d)30.97M
Market cap1.84B
RS 3m (vs SPY)-28.63%
RS 6m (vs SPY)+11.32%
RS line new highNo
Trend template6/8
Technical rank63.3
1 week+6.40%
1 month-7.92%
3 months-15.75%
6 months+21.87%
1 year+217.56%
YTD+15.45%
P/E-15.34
P/B4.75
P/S—
P/FCF-19.30
EPS-2.01
Div yield—
ROE-30.95%
ROA-29.11%
Debt/Eq—
Current20.49
EV/EBITDA-13.27
Gross margin—
Net margin—
Rev growth—
EPS growth-38.70%
Price target50.33
Target upside62.72%
Analyst ratingBuy
Institutional114.34%
Ent. value1.75B
Revenue—
Net income-39.3M
Gross profit—
Free cash flow-95.28M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out59.47M
Employees87
ListedWed, Sep 15, 2021
Free float28.09M
Float %52.1%
Short interest9.28M
Days to cover13.1d
Short volume82.6%
Squeeze score95 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.64 vs −$0.60
Last surprise-6.7% miss
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank63.3 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree white soldiers
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TYRA
No recent disclosed trades by Congress in TYRA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TYRA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shah Rajeev M. Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Kolchinsky Peter Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Simson Jake Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
MORE ROBERT J Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
RA Capital Nexus Fund, L.P. Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
RA Capital Healthcare Fund LP Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Verjee Rehan Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
RA CAPITAL MANAGEMENT, L.P. Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Moran Susan Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Rothenberg Stephen Michael Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
SEC filings
EDGAR filings in TYRA · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.